Instylla Logo

Materializing Solutions

Instylla delivers next-generation liquid embolics for interventional radiology, with initial clinical applications in interventional oncology and peripheral hemostasis.

LatesT news

Instylla announces positive results from preclinical studies of Embrace™ Hydrogel Embolic System in hemorrhage models

July 26, 2022

BEDFORD, Mass., – July 26, 2022 – Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced two publications that evaluated the Embrace™ Hydrogel Embolic System (HES) in preclinical porcine hemorrhage models. In a Journal of Vascular and Interventional Radiology (JVIR) publication, Dr. Gandras et al. evaluated[i] the ability […]

Read More